The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, Moira M Rachman, Patrick C O'Leary, Taha Y Taha, Yusuke Matsui, Francisco J Zapatero-Belinchón, Maria McCavitt-Malvido, Yagmur U Doruk, Maisie GV Stevens, Morgan E Diolaiti, Manasi P Jogalekar, Huadong Chen, Alicia L Richards, Pornparn Kongpracha, Sofia Bali, Mauricio Montano, Julia Rosecrans, Michael Matthay, Takaya Togo, Ryan L Gonciarz, Saumya Gopalkrishnan, R Jeffrey Neitz, Nevan J Krogan, Danielle L Swaney, Brian K Shoichet, Melanie Ott, Adam R Renslo, Alan Ashworth, James S Fraser. The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2. eLife. 2025 Nov 19; 14.

2025
https://researcherprofiles.org/profile/706344519

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, Moira M Rachman, Patrick C O'Leary, Taha Y Taha, Yusuke Matsui, Francisco J Zapatero-Belinchón, Maria McCavitt-Malvido, Yagmur U Doruk, Maisie GV Stevens, Morgan E Diolaiti, Manasi P Jogalekar, Huadong Chen, Alicia L Richards, Pornparn Kongpracha, Sofia Bali, Mauricio Montano, Julia Rosecrans, Michael Matthay, Takaya Togo, Ryan L Gonciarz, Saumya Gopalkrishnan, R Jeffrey Neitz, Nevan J Krogan, Danielle L Swaney, Brian K Shoichet, Melanie Ott, Adam R Renslo, Alan Ashworth, James S Fraser